263 related articles for article (PubMed ID: 35550867)
21. Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
Franke MF; Khan P; Hewison C; Khan U; Huerga H; Seung KJ; Rich ML; Zarli K; Samieva N; Oyewusi L; Nair P; Mudassar M; Melikyan N; Lenggogeni P; Lecca L; Kumsa A; Khan M; Islam S; Hussein K; Docteur W; Chumburidze N; Berikova E; Atshemyan H; Atwood S; Alam M; Ahmed S; Bastard M; Mitnick CD
Am J Respir Crit Care Med; 2021 Jan; 203(1):111-119. PubMed ID: 32706644
[No Abstract] [Full Text] [Related]
22. Multidrug-resistant tuberculosis and culture conversion with bedaquiline.
Diacon AH; Pym A; Grobusch MP; de los Rios JM; Gotuzzo E; Vasilyeva I; Leimane V; Andries K; Bakare N; De Marez T; Haxaire-Theeuwes M; Lounis N; Meyvisch P; De Paepe E; van Heeswijk RP; Dannemann B;
N Engl J Med; 2014 Aug; 371(8):723-32. PubMed ID: 25140958
[TBL] [Abstract][Full Text] [Related]
23. Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective
Kaniga K; Hasan R; Jou R; Vasiliauskienė E; Chuchottaworn C; Ismail N; Metchock B; Miliauskas S; Viet Nhung N; Rodrigues C; Shin S; Simsek H; Smithtikarn S; Ngoc ALT; Boonyasopun J; Kazi M; Kim S; Kamolwat P; Musteikiene G; Sacopon CA; Tahseen S; Vasiliauskaitė L; Wu MH; Vally Omar S
J Clin Microbiol; 2022 Jan; 60(1):e0291920. PubMed ID: 34705538
[TBL] [Abstract][Full Text] [Related]
24. Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study.
Derendinger B; Dippenaar A; de Vos M; Huo S; Alberts R; Tadokera R; Limberis J; Sirgel F; Dolby T; Spies C; Reuter A; Folkerts M; Allender C; Lemmer D; Van Rie A; Gagneux S; Rigouts L; Te Riele J; Dheda K; Engelthaler DM; Warren R; Metcalfe J; Cox H; Theron G
Lancet Microbe; 2023 Dec; 4(12):e972-e982. PubMed ID: 37931638
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China.
He W; Liu C; Liu D; Ma A; Song Y; He P; Bao J; Li Y; Zhao B; Fan J; Cheng Q; Zhao Y
J Glob Antimicrob Resist; 2021 Sep; 26():241-248. PubMed ID: 34214699
[TBL] [Abstract][Full Text] [Related]
26. Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutations.
Otum CC; Rivière E; Barnard M; Loubser J; Williams MJ; Streicher EM; Van Rie A; Warren RM; Klopper M
Sci Rep; 2023 Jun; 13(1):9212. PubMed ID: 37280265
[TBL] [Abstract][Full Text] [Related]
27. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
[TBL] [Abstract][Full Text] [Related]
28. Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
Peretokina IV; Krylova LY; Antonova OV; Kholina MS; Kulagina EV; Nosova EY; Safonova SG; Borisov SE; Zimenkov DV
J Infect; 2020 May; 80(5):527-535. PubMed ID: 31981638
[TBL] [Abstract][Full Text] [Related]
29. TMC207 becomes bedaquiline, a new anti-TB drug.
Palomino JC; Martin A
Future Microbiol; 2013 Sep; 8(9):1071-80. PubMed ID: 24020736
[TBL] [Abstract][Full Text] [Related]
30. Bedaquiline and delamanid in tuberculosis.
Esposito S; Bianchini S; Blasi F
Expert Opin Pharmacother; 2015; 16(15):2319-30. PubMed ID: 26293803
[TBL] [Abstract][Full Text] [Related]
31. Whole-genome sequencing reveals genetic signature of bedaquiline resistance in a clinical isolate of Mycobacterium tuberculosis.
Chawla K; Martinez E; Kumar A; Shenoy VP; Sintchenko V
J Glob Antimicrob Resist; 2018 Dec; 15():103-104. PubMed ID: 30248414
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment.
Nimmo C; Brien K; Millard J; Grant AD; Padayatchi N; Pym AS; O'Donnell M; Goldstein R; Breuer J; Balloux F
EBioMedicine; 2020 May; 55():102747. PubMed ID: 32361247
[TBL] [Abstract][Full Text] [Related]
33. Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis.
Nguyen TV; Cao TB; Akkerman OW; Tiberi S; Vu DH; Alffenaar JW
Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1025-37. PubMed ID: 27322153
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens.
Kempker RR; Mikiashvili L; Zhao Y; Benkeser D; Barbakadze K; Bablishvili N; Avaliani Z; Peloquin CA; Blumberg HM; Kipiani M
Clin Infect Dis; 2020 Dec; 71(9):2336-2344. PubMed ID: 31712809
[TBL] [Abstract][Full Text] [Related]
35. Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan.
Ghodousi A; Rizvi AH; Baloch AQ; Ghafoor A; Khanzada FM; Qadir M; Borroni E; Trovato A; Tahseen S; Cirillo DM
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262765
[TBL] [Abstract][Full Text] [Related]
36. Emergence of Canonical and Noncanonical Genomic Variants following
Ismail N; Dippenaar A; Warren RM; Peters RPH; Omar SV
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0136822. PubMed ID: 36892309
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
Mbuagbaw L; Guglielmetti L; Hewison C; Bakare N; Bastard M; Caumes E; Fréchet-Jachym M; Robert J; Veziris N; Khachatryan N; Kotrikadze T; Hayrapetyan A; Avaliani Z; Schünemann HJ; Lienhardt C
Emerg Infect Dis; 2019 May; 25(5):936-943. PubMed ID: 31002070
[TBL] [Abstract][Full Text] [Related]
38. Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan.
Saeed DK; Shakoor S; Razzak SA; Hasan Z; Sabzwari SF; Azizullah Z; Kanji A; Nasir A; Shafiq S; Ghanchi NK; Hasan R
BMC Microbiol; 2022 Feb; 22(1):62. PubMed ID: 35209842
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia.
Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Subay S; Adiono SH
Int J Mycobacteriol; 2024 Apr; 13(2):140-146. PubMed ID: 38916383
[TBL] [Abstract][Full Text] [Related]
40. Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains.
Battaglia S; Spitaleri A; Cabibbe AM; Meehan CJ; Utpatel C; Ismail N; Tahseen S; Skrahina A; Alikhanova N; Mostofa Kamal SM; Barbova A; Niemann S; Groenheit R; Dean AS; Zignol M; Rigouts L; Cirillo DM
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32907992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]